Woodley BioReg is excited to announce our attendance at Dubai Derma in April 2025. As specialists in regulatory affairs and quality assurance for the pharmaceutical, biotechnology, and medical device industries, we understand the critical importance of regulation in ensuring the safety, efficacy, and compliance of dermatological and skincare products.
The growing importance of skincare regulation
The skincare and dermatology industries are rapidly evolving, with biopharmaceutical innovations, personalised treatments, and aesthetic technologies pushing boundaries. But with innovation comes responsibility. Robust and forward-looking regulatory frameworks are essential to ensure that new skincare solutions meet the highest standards of safety and effectiveness.
At Woodley BioReg, we support companies worldwide in the certification, registration, and development of dermatological products—from botulinum toxins and dermal fillers to skin boosters and regenerative treatments. Our attendance at Dubai Derma will allow us to share this expertise, connect with industry leaders, and explore new ways to streamline regulatory pathways across emerging and established markets.
Navigating regulation across the UK and MENA regions
In the UK, oversight of skincare products—particularly those with therapeutic claims—falls under the remit of the Medicines and Healthcare products Regulatory Agency (MHRA). Compliance is built on strong evidence of clinical benefit, patient safety, and product quality.
In contrast, regulatory pathways across the Middle East and North Africa (MENA) are still developing. Manufacturers and distributors must be proactive in understanding and adapting to these changes. To learn more about how the MHRA regulates borderline products, see their official guidance.
At Dubai Derma 2025, Woodley BioReg will be contributing to conversations around how skincare and dermatology products can achieve multi-regional compliance, helping businesses unlock market access in a globally competitive field.
Why attend Dubai Derma?
Dubai Derma is the largest event dedicated to skincare science and aesthetics in the MENA and Indian Subcontinent regions. Now in its 24th edition, the conference unites key decision-makers, dermatologists, product developers, and regulatory experts.
With trends such as personalised medicine, regenerative aesthetics, and biotech-led skincare gaining traction, it is crucial for regulatory strategies to evolve accordingly. Events like Dubai Derma offer a platform for sharing insights, refining best practices, and addressing regulatory challenges unique to this fast-moving field.
Looking ahead
Woodley BioReg is committed to helping companies navigate complex regulatory environments, ensuring that innovations in skincare are brought to market safely and efficiently.
By attending Dubai Derma, we aim to collaborate with manufacturers, distributors, and innovators seeking clarity in regulatory strategy. Whether you’re preparing a new product for the MENA market or seeking global regulatory alignment, we’re here to help.
If you’re attending Dubai Derma, we’d love to connect. Click here to arrange a meeting and explore how Woodley BioReg can support your regulatory and quality assurance needs.
Back to News + Insights